Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel decarboxylative cross-coupling process for high-purity cardiovascular drug intermediates. Reduces steps and improves yield compared to Suzuki methods.
Patent CN108002966B details a safe Ni(II) catalyzed cross-coupling method. Discover cost-effective manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN110804038B reveals a safer zinc-catalyzed route for tedizolid phosphate intermediates, offering high purity and industrial scalability for API manufacturing.
Novel copper-catalyzed method for trifluoro ethyl phenylacetylene intermediates. Enhances yield and reduces costs for pharmaceutical manufacturing supply chains.
Patent CN107935802A reveals a mild Suzuki coupling method using arylsulfonyl fluoride. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN113480416A details a mild, nickel-catalyzed route for aryl ketones, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN111004190A reveals a robust Suzuki coupling route for aprepitant intermediates, offering safer scale-up and cost reduction in API manufacturing.
Patent CN105859774A reveals a high-yield palladium-catalyzed synthesis route. This breakthrough ensures supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Advanced Ir-catalyzed photocross-coupling method for hydrazide compounds. Delivers high purity, mild reaction conditions, and cost-effective manufacturing solutions for reliable global pharmaceutical intermediate supply chains.
Patent CN115260085A reveals a safer Pd-catalyzed route for 3-nitro-9-ethylcarbazole. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN110590621A reveals a copper-catalyzed route for sulfone derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110903242A reveals a safer, high-yield route for Roxadustat intermediates. Discover cost-effective manufacturing solutions for HIF-PHI inhibitors.
Discover advanced synthesis routes for potent tetrahydrocarbazole derivatives. Enhance your anti-tuberculosis pipeline with high-yield, scalable pharmaceutical intermediates.
Discover cost-effective Honokiol synthesis via patent CN108430463A. Enhanced purity and scalable manufacturing for pharmaceutical intermediates supply chains.
Novel Pd-NHC catalyzed process offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability for global partners.
Novel deep blue emitter with balanced carrier transport. Efficient Ni-catalyzed synthesis offers cost advantages for electronic chemical manufacturing.
Patent CN114605452A reveals a thermally stable fluoroboron compound with large Stokes shift, offering cost reduction in electronic chemical manufacturing.
Discover advanced synthesis routes for 3,4,5-trisubstituted isoxazoles with potent antitumor activity. Optimized for scalable API manufacturing and cost-effective procurement.
Patent CN111269228A reveals a green photocatalytic route for fluorescent indolizine derivatives, offering cost-effective manufacturing for pharma intermediates.
Patent CN116283515A reveals a direct cross-coupling method using aryl fluorides and bromides. This technology offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.